These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 32900927)
21. Pharmacological depletion of microglia and perivascular macrophages prevents Vascular Cognitive Impairment in Ang II-induced hypertension. Kerkhofs D; van Hagen BT; Milanova IV; Schell KJ; van Essen H; Wijnands E; Goossens P; Blankesteijn WM; Unger T; Prickaerts J; Biessen EA; van Oostenbrugge RJ; Foulquier S Theranostics; 2020; 10(21):9512-9527. PubMed ID: 32863942 [No Abstract] [Full Text] [Related]
22. Role of Macrophage Colony-Stimulating Factor Receptor on the Proliferation and Survival of Microglia Following Systemic Nerve and Cuprizone-Induced Injuries. Pons V; Laflamme N; Préfontaine P; Rivest S Front Immunol; 2020; 11():47. PubMed ID: 32082318 [TBL] [Abstract][Full Text] [Related]
23. Colony-stimulating factor 1 receptor inhibition prevents microglial plaque association and improves cognition in 3xTg-AD mice. Dagher NN; Najafi AR; Kayala KM; Elmore MR; White TE; Medeiros R; West BL; Green KN J Neuroinflammation; 2015 Aug; 12():139. PubMed ID: 26232154 [TBL] [Abstract][Full Text] [Related]
24. Microglia are required for protection against lethal coronavirus encephalitis in mice. Wheeler DL; Sariol A; Meyerholz DK; Perlman S J Clin Invest; 2018 Mar; 128(3):931-943. PubMed ID: 29376888 [TBL] [Abstract][Full Text] [Related]
25. Microglia are not necessary for maintenance of blood-brain barrier properties in health, but PLX5622 alters brain endothelial cholesterol metabolism. Profaci CP; Harvey SS; Bajc K; Zhang TZ; Jeffrey DA; Zhang AZ; Nemec KM; Davtyan H; O'Brien CA; McKinsey GL; Longworth A; McMullen TP; Capocchi JK; Gonzalez JG; Lawson DA; Arnold TD; Davalos D; Blurton-Jones M; Dabertrand F; Bennett FC; Daneman R Neuron; 2024 Sep; 112(17):2910-2921.e7. PubMed ID: 39142282 [TBL] [Abstract][Full Text] [Related]
26. CSF1R inhibition with PLX5622 affects multiple immune cell compartments and induces tissue-specific metabolic effects in lean mice. Bosch AJT; Keller L; Steiger L; Rohm TV; Wiedemann SJ; Low AJY; Stawiski M; Rachid L; Roux J; Konrad D; Wueest S; Tugues S; Greter M; Böni-Schnetzler M; Meier DT; Cavelti-Weder C Diabetologia; 2023 Dec; 66(12):2292-2306. PubMed ID: 37792013 [TBL] [Abstract][Full Text] [Related]
28. Microglia prevent peripheral immune cell invasion and promote an anti-inflammatory environment in the brain of APP-PS1 transgenic mice. Unger MS; Schernthaner P; Marschallinger J; Mrowetz H; Aigner L J Neuroinflammation; 2018 Sep; 15(1):274. PubMed ID: 30241479 [TBL] [Abstract][Full Text] [Related]
29. A MAC2-positive progenitor-like microglial population is resistant to CSF1R inhibition in adult mouse brain. Zhan L; Fan L; Kodama L; Sohn PD; Wong MY; Mousa GA; Zhou Y; Li Y; Gan L Elife; 2020 Oct; 9():. PubMed ID: 33054973 [TBL] [Abstract][Full Text] [Related]
30. Treatment With the CSF1R Antagonist GW2580, Sensitizes Microglia to Reactive Oxygen Species. Soto-Diaz K; Vailati-Riboni M; Louie AY; McKim DB; Gaskins HR; Johnson RW; Steelman AJ Front Immunol; 2021; 12():734349. PubMed ID: 34899694 [TBL] [Abstract][Full Text] [Related]
31. CSF1R Ligands IL-34 and CSF1 Are Differentially Required for Microglia Development and Maintenance in White and Gray Matter Brain Regions. Easley-Neal C; Foreman O; Sharma N; Zarrin AA; Weimer RM Front Immunol; 2019; 10():2199. PubMed ID: 31616414 [TBL] [Abstract][Full Text] [Related]
32. The Behavioral Sequelae of Social Defeat Require Microglia and Are Driven by Oxidative Stress in Mice. Lehmann ML; Weigel TK; Poffenberger CN; Herkenham M J Neurosci; 2019 Jul; 39(28):5594-5605. PubMed ID: 31085604 [TBL] [Abstract][Full Text] [Related]
33. CSF1R antagonism results in increased supraspinal infiltration in EAE. Wang M; Caryotakis SE; Smith GG; Nguyen AV; Pleasure DE; Soulika AM J Neuroinflammation; 2024 Apr; 21(1):103. PubMed ID: 38643194 [TBL] [Abstract][Full Text] [Related]
34. Early posttraumatic CSF1R inhibition via PLX3397 leads to time- and sex-dependent effects on inflammation and neuronal maintenance after traumatic brain injury in mice. Wang Y; Wernersbach I; Strehle J; Li S; Appel D; Klein M; Ritter K; Hummel R; Tegeder I; Schäfer MKE Brain Behav Immun; 2022 Nov; 106():49-66. PubMed ID: 35933030 [TBL] [Abstract][Full Text] [Related]
35. Underestimated Peripheral Effects Following Pharmacological and Conditional Genetic Microglial Depletion. Han J; Fan Y; Zhou K; Zhu K; Blomgren K; Lund H; Zhang XM; Harris RA Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33203068 [TBL] [Abstract][Full Text] [Related]
36. Distinguishing the effects of systemic CSF1R inhibition by PLX3397 on microglia and peripheral immune cells. Okojie AK; Uweru JO; Coburn MA; Li S; Cao-Dao VD; Eyo UB J Neuroinflammation; 2023 Oct; 20(1):242. PubMed ID: 37865779 [TBL] [Abstract][Full Text] [Related]
37. Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo. Oosterhof N; Kuil LE; van der Linde HC; Burm SM; Berdowski W; van Ijcken WFJ; van Swieten JC; Hol EM; Verheijen MHG; van Ham TJ Cell Rep; 2018 Jul; 24(5):1203-1217.e6. PubMed ID: 30067976 [TBL] [Abstract][Full Text] [Related]
38. Attenuation of neuroinflammation reverses Adriamycin-induced cognitive impairments. Allen BD; Apodaca LA; Syage AR; Markarian M; Baddour AAD; Minasyan H; Alikhani L; Lu C; West BL; Giedzinski E; Baulch JE; Acharya MM Acta Neuropathol Commun; 2019 Nov; 7(1):186. PubMed ID: 31753024 [TBL] [Abstract][Full Text] [Related]
39. Targeting macrophage and microglia activation with colony stimulating factor 1 receptor inhibitor is an effective strategy to treat injury-triggered neuropathic pain. Lee S; Shi XQ; Fan A; West B; Zhang J Mol Pain; 2018; 14():1744806918764979. PubMed ID: 29546785 [TBL] [Abstract][Full Text] [Related]
40. Zebrafish macrophage developmental arrest underlies depletion of microglia and reveals Csf1r-independent metaphocytes. Kuil LE; Oosterhof N; Ferrero G; Mikulášová T; Hason M; Dekker J; Rovira M; van der Linde HC; van Strien PM; de Pater E; Schaaf G; Bindels EM; Wittamer V; van Ham TJ Elife; 2020 May; 9():. PubMed ID: 32367800 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]